192. Deputy Jennifer Whitmore asked the Minister for Health if the free HRT scheme will have any impact on recipients of the drug payment scheme, in particular in instances where their selected pharmacy is not signed up to the free HRT scheme; and if she will make a statement on the matter. [24632/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
194. Deputy Michael Cahill asked the Minister for Health the strategies in place to ensure the continuous supply of prescription drugs to pharmacies throughout the country (details supplied); and if she will make a statement on the matter. [24664/25]
113. Deputy Marie Sherlock asked the Minister for Health the action she has taken to ensure that community pharmacists will administer the free hormone replacement therapy, HRT, scheme from 1 June 2025; and if she will make a statement on the matter. [24511/25]
130. Deputy Pádraig O'Sullivan asked the Minister for Health the progress made regarding commitments in the Programme for Government surrounding rare diseases and specifically plans for a review of the drug reimbursement process, increasing the number of clinical trials and providing an early access scheme for new drug and treatment; and if she will make a statement on the matter. [23511/25]
175. Deputy Michael Cahill asked the Minister for Health if Pluvicto, the new, life-changing prostate cancer medication that has been approved by the European Medicines Agency, will be made available to all public patients at the earliest possible date; the estimated full year cost of providing this treatment; and if she will make a statement on the matter. [23673/25]
192. Deputy Shane Moynihan asked the Minister for Health to outline her engagements with the HSE on access to givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [23725/25]
193. Deputy Grace Boland asked the Minister for Health the work her Department has undertaken to engage with the manufacturers of HRT products to minimise any supply chain issues; and if she will make a statement on the matter. [24048/25]
201. Deputy James O'Connor asked the Minister for Health the means by which she will ensure that patients have access to new innovative medicines and treatments as quickly as possible, especially for rare diseases; and if she will make a statement on the matter. [24095/25]
1000. Deputy Richard Boyd Barrett asked the Minister for Health for an overview of the primary and secondary legislation regulating medical advertising and labelling, in particular the legislation regulating what health and medical claims sellers can make about their products. [23187/25]
1033. Deputy Michael Cahill asked the Minister for Health if she will request the HSE to make the new, life changing prostate cancer therapy, pluvicto, a treatment that has been approved by the European Medicines Agency, available to all public patients at the earliest possible date; the cost of this treatment; how soon will it be available to patients in Ireland; and if she will make a statement on the matter. [2346…
443. Deputy Peter 'Chap' Cleere asked the Minister for Health the reason evorel 50mg and estradot mg are not currently covered on GMS scheme which results in patient has to pay privately for this; and if she will make a statement on the matter. [23064/25]
414. Deputy John Brady asked the Minister for Health if there are plans to carry out an inquiry into the historical licensing and prescribing of sodium valproate; if so when this inquiry will be carried out; and if she will make a statement on the matter. [22044/25]
267. Deputy Liam Quaide asked the Minister for Health her plans to introduce a nationwide scheme to allow people return unused or out of date medication to pharmacies; and if she will make a statement on the matter. [21684/25]
2005. Deputy David Cullinane asked the Minister for Health if she accepts that the delay in delivering free HRT to women is unacceptable; the steps she has taken to deliver on commitments given; if she further accepts that failure in this areas does not rest with pharmacists; and if she will make a statement on the matter. [18692/25]
2051. Deputy Máire Devine asked the Minister for Health if she is aware that the prescribed medication solpadeine is covered on the medical card but dissolvable solpadeine is not and dissolvable solpadeine is the only effective pain management medication for some patients, namely a person (details supplied); the reason this solpadeine product is not included in medical card coverage; if she will consider including it…
2071. Deputy Duncan Smith asked the Minister for Health if she will approve of and provide funding for the combination treatment of ibrutinib and venetoclax for the treatment of chronic lymphocytic leukaemia; and if she will make a statement on the matter. [19124/25]
2096. Deputy Shane Moynihan asked the Minister for Health when medication known as givinostat will be made available in the State, given the role it can play in treating Duchenne muscular dystrophy in young boys. [19252/25]
2105. Deputy Naoise Ó Muirí asked the Minister for Health if she will consider introducing legislation (details supplied); and if she will make a statement on the matter. [19274/25]
2182. Deputy Barry Heneghan asked the Minister for Health if she will examine the cost of the anti-sickness medication cariban for pregnant women (details supplied); and if she will make a statement on the matter. [19605/25]
2199. Deputy Marie Sherlock asked the Minister for Health if she intends on introducing the shingles vaccine for chronic lymphocytic leukaemia patients under the medical card or drug payment scheme; and if she will make a statement on the matter. [19692/25]
2206. Deputy Jennifer Whitmore asked the Minister for Health if a system is in place that enables women to access free HRT by only paying the dispensing fee to the pharmacist and not paying for the medication itself; and if she will make a statement on the matter. [19715/25]
2207. Deputy Jennifer Whitmore asked the Minister for Health for an update on the roll-out of the free HRT scheme; and if she will make a statement on the matter. [19716/25]
2240. Deputy Michael Murphy asked the Minister for Health how individuals over the age of 60 who are at a high risk from diabetes, and thus not suitable for the Pfizer vaccination, can access Novavax. [19839/25]
2246. Deputy Cathy Bennett asked the Minister for Health if women will be provided backdated payments for HRT arising from the scheme being delayed since January; and if she will make a statement on the matter. [19858/25]
2293. Deputy Rose Conway-Walsh asked the Minister for Health the reason for the delay to the introduction of free HRT medication which was to be available from January 2025; when it will be freely available; the process for accessing this medication; and if she will make a statement on the matter. [20122/25]